GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabpharm Ltd (HKSE:02181) » Definitions » Price-to-Free-Cash-Flow

Mabpharm (HKSE:02181) Price-to-Free-Cash-Flow : 34.50 (As of May. 31, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Mabpharm Price-to-Free-Cash-Flow?

As of today (2024-05-31), Mabpharm's share price is HK$0.345. Mabpharm's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.01. Hence, Mabpharm's Price-to-Free-Cash-Flow Ratio for today is 34.50.

The historical rank and industry rank for Mabpharm's Price-to-Free-Cash-Flow or its related term are showing as below:

HKSE:02181' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 29   Med: 45   Max: 50
Current: 34.5

During the past 7 years, Mabpharm's highest Price-to-Free-Cash-Flow Ratio was 50.00. The lowest was 29.00. And the median was 45.00.

HKSE:02181's Price-to-Free-Cash-Flow is ranked worse than
53.81% of 210 companies
in the Biotechnology industry
Industry Median: 30.41 vs HKSE:02181: 34.50

Mabpharm's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was HK$0.01.

During the past 7 years, Mabpharm's highest 3-Year average Free Cash Flow per Share Growth Rate was 12.40% per year. The lowest was -65.10% per year. And the median was -34.90% per year.


Mabpharm Price-to-Free-Cash-Flow Historical Data

The historical data trend for Mabpharm's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabpharm Price-to-Free-Cash-Flow Chart

Mabpharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - 46.00

Mabpharm Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 46.00

Competitive Comparison of Mabpharm's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Mabpharm's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mabpharm's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mabpharm's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Mabpharm's Price-to-Free-Cash-Flow falls into.



Mabpharm Price-to-Free-Cash-Flow Calculation

Mabpharm's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.345/0.01
=34.50

Mabpharm's Share Price of today is HK$0.345.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mabpharm's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Mabpharm  (HKSE:02181) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Mabpharm Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Mabpharm's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Mabpharm (HKSE:02181) Business Description

Traded in Other Exchanges
N/A
Address
Lujia Road East, Koutai Road West, Block G79, China Medical City, Taizhou, CHN, 225300
Mabpharm Ltd is a biopharmaceutical company. The company is engaged in the research, development, and production of new drugs and biosimilars for cancers and autoimmune diseases. Its core products include CMAB008 (infliximab), CMAB007 (omalizumab), and CMAB009 (cetuximab).
Executives
Guo Jianjun 2307 Founder of a discretionary trust who can infl
Asia Mabtech Limited
Asia Pacific Immunotech Venture Limited
Guo Family (ptc) Limited
Fortune-healthy Investment Limited
Link Best Capital Limited
Cdh Fund V, L.p.
Cdh Mabtech Limited
Cdh V Holdings Company Limited
China Diamond Holdings Company Limited
China Diamond Holdings V Limited

Mabpharm (HKSE:02181) Headlines

No Headlines